Produção Nacional
Revisado por pares
The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
2020; Wiley; Volume: 76; Issue: 3 Linguagem: Inglês
10.1111/all.14687
ISSN1398-9995
AutoresEmek Kocatürk, Andaç Salman, Iván Chérrez-Ojeda, Paulo Ricardo Criado, Jonny Peter, Elif Cömert-Özer, Mohamed Abuzakouk, Rosana Câmara Agondi, Mona Al‐Ahmad, Sabine Altrichter, Rand Arnaout, L. Karla Arruda, Riccardo Asero, Andrea Bauer, Moshe Ben‐Shoshan, Jonathan A. Bernstein, Mojca Bizjak, Isabelle Boccon‐Gibod, Hanna Bonnekoh, Laurence Bouillet, Zenon Brzoza, Paula Busse, Régis A. Campos, Emily Carne, Niall Conlon, Roberta Fachini Jardim Criado, Eduardo Magalhães de Souza Lima, Semra Demir, Joachim Dissemond, Sibel Doğan, Irina V. Dorofeeva, Luís Felipe Ensina, Ragıp Ertaş, Silvia Mariel Ferrucci, Ignasi Figueras‐Nart, Daria Fomina, Sylvie M. Franken, Atsushi Fukunaga, Ana M. Giménez‐Arnau, Kiran Godse, Margarida Gonçalo, Maia Gotua, Clive Grattan, Carole Guillet, Naoko Inomata, Thilo Jakob, Gül Karakaya, Alicja Kasperska−Zając, Constance H. Katelaris, Mitja Košnik, Dorota Krasowska, Kanokvalai Kulthanan, Muthu Sendhil Kumaran, Claudia Lang, José Ignacio Larco‐Sousa, Elisavet Lazaridou, Tabi A. Leslie, Undine Lippert, Oscar Calderón Llosa, Michaël Makris, Alexander Marsland, Iris Medina, Raisa Meshkova, Esther Bastos Palitot, Claudio Alberto Salvador Parisi, Julia Pickert, German D. Ramón, Mónica Rodríguez-González, Nelson Augusto Rosário Filho, Michael Rudenko, Krzysztof Rutkowski, Jorge Sánchez, Sibylle Schliemann, Bülent Enis Şekerel, Faradiba Sarquis Serpa, E. Serra‐Baldrich, Zhiqiang Song, A. Soria, Maria Staevska, Petra Staubach, Anna Tagka, Shunsuke Takahagi, Simon Francis Thomsen, Regina Treudler, Zahava Vadasz, Solange Oliveira Rodrigues Valle, Martijn B. A. van Doorn, Christian Vestergaard, Nicola Wagner, Dahu Wang, Liangchun Wang, Bettina Wedi, Paraskevi Xepapadaki, Esra Yücel, Anna Zalewska‐Janowska, Zuotao Zhao, Torsten Zuberbier, Marcus Maurer,
Tópico(s)Mast cells and histamine
ResumoThe COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown.To understand how CU patients are affected by the COVID-19 pandemic; how specialists alter CU patient management; and the course of CU in patients with COVID-19.Our cross-sectional, international, questionnaire-based, multicenter UCARE COVID-CU study assessed the impact of the pandemic on patient consultations, remote treatment, changes in medications, and clinical consequences.The COVID-19 pandemic severely impairs CU patient care, with less than 50% of the weekly numbers of patients treated as compared to before the pandemic. Reduced patient referrals and clinic hours were the major reasons. Almost half of responding UCARE physicians were involved in COVID-19 patient care, which negatively impacted on the care of urticaria patients. The rate of face-to-face consultations decreased by 62%, from 90% to less than half, whereas the rate of remote consultations increased by more than 600%, from one in 10 to more than two thirds. Cyclosporine and systemic corticosteroids, but not antihistamines or omalizumab, are used less during the pandemic. CU does not affect the course of COVID-19, but COVID-19 results in CU exacerbation in one of three patients, with higher rates in patients with severe COVID-19.The COVID-19 pandemic brings major changes and challenges for CU patients and their physicians. The long-term consequences of these changes, especially the increased use of remote consultations, require careful evaluation.
Referência(s)